Literature DB >> 12777968

Thiopurine methyltransferase phenotypes and genotypes in Brazilians.

Marcelo Reis1, Ana Santoro, Guilherme Suarez-Kurtz.   

Abstract

The polymorphism of thiopurine methyltransferase (TPMT) was studied in 306 healthy Brazilians who were classed, on the basis of self-declared colour and ancestry, as Euro-derived (n = 81), Afro-derived (n = 18) or having interethnic admixture (n = 204). TPMT activity (range 0.17-25.93 U) displayed a trimodal distribution of high (> 11.3 U; 9% of individuals), intermediate (5-11.3 U; 9.8%) and low (0.17 U; 0.3%) phenotypes. The occurrence of the TPMT mutations 238G>C, 460G>A and 719A>G was investigated in all individuals with low or intermediate phenotype, and in 43 with high-activity phenotype. None and two mutant alleles were associated with high- or low-activity phenotypes, respectively, whereas one mutant allele was detected in 26 of the 30 intermediate phenotype individuals. The allele frequencies of TPMT*2, TPMT*3A and TPMT*3C did not differ between individuals classed as Euro-derived (0.76%, 2.03% and 2.54%, respectively) or having interethnic admixture (0.60%, 1.81% and 1.81%, respectively). Furthermore, within each of these groups, the frequencies of TPMT*3A and TPMT*3C were not significantly different.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777968     DOI: 10.1097/00008571-200306000-00009

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  10 in total

Review 1.  The thiopurines: an update.

Authors:  Sally Coulthard; Linda Hogarth
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

2.  Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.

Authors:  Lilla M Roy; Richard M Zur; Elizabeth Uleryk; Chris Carew; Shinya Ito; Wendy J Ungar
Journal:  Pharmacogenomics       Date:  2016-03-29       Impact factor: 2.533

3.  Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore.

Authors:  Shirley Kow Yin Kham; Chin Kok Soh; Te Chih Liu; Yiong Huak Chan; Hany Ariffin; Poh Lin Tan; Allen Eng Juh Yeoh
Journal:  Eur J Clin Pharmacol       Date:  2008-01-11       Impact factor: 2.953

4.  Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.

Authors:  Ana Teresa P Carvalho; Barbara C Esberard; Renata S B Fróes; Davy C M Rapozo; Ana B Grinman; Tatiana A Simão; Juliana C V C Santos; Antonio José V Carneiro; Luis Felipe Ribeiro-Pinto; Heitor S P de Souza
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients.

Authors:  Lucia Taja-Chayeb; Silvia Vidal-Millán; Olga Gutiérrez; Patricia Ostrosky-Wegman; Alfonso Dueñas-González; Myrna Candelaria
Journal:  Med Oncol       Date:  2007-09-06       Impact factor: 3.064

6.  Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population.

Authors:  Raju Murugesan; Saadi Abdul Vahab; Satyajit Patra; Rekha Rao; Jyothi Rao; Padmalatha Rai; P M Gopinath; Kapaettu Satyamoorthy
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

7.  Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil.

Authors:  Ricardo Ventura Santos; Gláucia Oliveira da Silva; Sahra Gibbon
Journal:  Biosocieties       Date:  2015-03-01

Review 8.  Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.

Authors:  Vid Mlakar; Patricia Huezo-Diaz Curtis; Chakradhara Rao Satyanarayana Uppugunduri; Maja Krajinovic; Marc Ansari
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

9.  Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values.

Authors:  Ayorinde Adehin; Oluseye O Bolaji
Journal:  BMC Res Notes       Date:  2018-02-14

Review 10.  Pharmacogenetic testing in oncology: a Brazilian perspective.

Authors:  Guilherme Suarez-Kurtz
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.